The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas

Neurochemistry International

Volumn 61, Issue 7, 2012, Pages 1183-1191

  Held Feindt, Janka ^a   Schmelz, Sabine ^a   Hattermann, Kirsten ^b   Mentlein, Rolf ^b   Mehdorn, H Maximilian ^a   Sebens, Susanne ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

CD171; Chemoresistance; Glioblastoma; L1CAM; Stem cells; TGF 1

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; LYMPHOCYTE ANTIGEN; NEURAL ADHESION MOLECULE L1CAM; SMALL INTERFERING RNA; TEMOZOLOMIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; INHIBITION KINETICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; UPREGULATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; NEURAL CELL ADHESION MOLECULE L1; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84870062168     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.08.011     Document Type: Article

References (37)

1. A. Arlt, J. Vorndamm, M. Breitenbroich, U.R. Fölsch, H. Kalthoff, W.E. Schmidt, and H. Schäfer Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin Oncogene 20 2001 859 868
2. S. Bao, Q. Wu, l. Zhizhong, S. Satornsumetee, H. Wang, R.E. McLendon, A.B. Hjelmeland, and J.N. Rich Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res. 68 2008 6043 6048
3. Q.W. Ben, J.C. Wan, J. Li, Y. Zhu, F. Yuan, W.Y. Yao, and Y.Z. Yuan Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma Ann. Surg. Oncol. 17 2010 2213 2221
4. F. Bergmann, F. Wandschneider, B. Sipos, G. Moldenhauer, B. Schniewind, T. Welsch, P. Schirrmacher, G. Klöppel, P. Altevogt, H. Schäfer, and S. Sebens Müerköster Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma Oncol. Rep. 24 2010 909 915
5. L. Cheng, Q. Wu, O.A. Guryanova, Z. Huang, Q. Huang, J.N. Rich, and S. Bao Elevated invasive potential of glioblastoma stem cells Biochem. Biophys. Res. Commun. 406 2011 643 648
6. L. Cheng, Q. Wu, Z. Huang, O.A. Guryanova, Q. Huang, W. Shou, J.N. Rich, and S. Bao L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NSB1 EMBO J. 30 2011 800 813
7. F.G. Davies, V. Kupelian, S. Freels, B. McCarthy, and T. Surawicz Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro Oncol. 3 2001 152 158
8. K. Doberstein, A. Wieland, S.B. Lee, R.A. Blaheta, S. Wedel, H. Moch, P. Schraml, J. Pfeilschifter, G. Kristiansen, and P. Gutwein L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells Carcinogenesis 32 2011 262 270
9. M. Fogel, P. Gutwein, S. Mechtersheimer, S. Riedle, A. Stoeck, A. Smirnov, L. Edler, A. Ben-Arie, M. Huszar, and P. Altevogt L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas Lancet 362 2003 869 875
10. N. Gavert, M. Conacci-Sorrell, D. Gast, A. Schneider, P. Altevogt, T. Brabletz, and A. Ben-Ze'ev L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers J. Biol. Chem. 168 2005 633 642
11. C. Geismann, M. Morscheck, D. Koch, F. Bergmann, H. Ungefroren, A. Arlt, M.-S. Tsao, M.G. Bachem, P. Altevogt, B. Sipos, U.R. Fölsch, H. Schäfer, and S. Sebens Müerköster Up-regulation of L1CAM in pancreatic ductal cells is transforming growth β1- and Slug-dependent: role in malignant transformation of pancreatic cancer Cancer Res. 69 2009 4517 4526
12. C. Geismann, A. Arlt, I. Bauer, M. Pfeiffer, U. Schirmer, P. Altevogt, S. Sebens Müerköster, and H. Schäfer Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGFβ)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells Int. J. Oncol. 38 2011 257 266
13. N. Golestaneh, and B. Mishra TGF-beta, neuronal stem cells and glioblastoma Oncogene 22 2005 5722 5730
14. K. Hattermann, J. Held-Feindt, R. Lucius, S. Sebens Müerköster, M.E.T. Penfold, T.J. Schall, and R. Mentlein The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates anti-apoptotic effects Cancer Res. 70 2010 3299 3308
15. J. Held-Feindt, and R. Mentlein CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors Int. J. Cancer 98 2002 352 356
16. J. Held-Feindt, K. Hattermann, S. Sebens Müerköster, H. Wedderkopp, F. Knerlich-Lukoschus, H. Ungefroren, H.M. Mehdorn, and R. Mentlein CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs) Exp. Cell Res. 316 2010 1553 1566
17. S. Izumoto, T. Ohnishi, N. Arita, S. Hiraga, T. Taki, and T. Hayakawa Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion Cancer Res. 56 1996 1440 1444
18. O.O. Kanu, A. Mehta, C. Di, N. Lin, K. Bortoff, D.D. Bigner, H. Yan, and D.C. Adamson Glioblastoma multiforme: a review of therapeutic targets Expert Opin. Ther. Targets 13 2009 701 718
19. T. Maretzky, M. Schulte, A. Ludwig, S. Rose-John, C. Blobel, D. Hartmann, P. Altevogt, P. Saftig, and K. Reiss L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth Mol. Cell Biol. 25 2005 9040 9053
20. S. Mechtersheimer, P. Gutwein, N. Agmon-Levin, A. Stoeck, M. Oleszewski, S. Riedle, R. Postina, F. Fahrenholz, M. Fogel, V. Lemmon, and P. Altevogt Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins J. Cell Biol. 155 2001 661 673
21. C. Nieder, M. Adam, and A.L. Grosu Combined modality treatment of glioblastoma multiforme: the role of temozolomide Rev. Recent Clin. Trials 1 2006 43 51
22. S. Raveh, N. Gavert, and A. Ben-Ze'ev L1 cell adhesion molecule (L1CAM) in invasive tumors Cancer Lett. 282 2009 137 145
23. T. Rawnaq, A. Quaas, H. Zander, S.J. Gros, U. Reichelt, M. Blessmann, W. Wilzcak, M. Schachner, G. Sauter, J.R. Izbicki, and J.T. Kaifi L1 is Highly expressed in tumors of the nervous system: a study of over 8000 human tissues J. Surg. Rev. 2010 2010 10.1016/j.jss.2010.10.029
24. B.A. Reynolds, and S. Weiss Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system Science 255 1992 1707 1710
25. M.K.E. Schäfer, and P. Altevogt L1CAM malfunction in the nervous system and human carcinomas Cell. Mol. Life Sci. 67 2010 2423 2437
26. S. Sebens Müerköster, J. Lust, A. Arlt, R. Hasler, M. Witt, T. Sebens, S. Schreiber, U.R. Fölsch, and H. Schäfer Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases Oncogene 25 2006 3973 3981
27. S. Sebens Müerköster, V. Werbing, B. Sipos, M.A. Debus, M. Witt, M. Großmann, D. Leisner, J. Kötteritzsch, H. Kappes, G. Klöppel, P. Altevogt, U.R. Fölsch, and H. Schäfer Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells Oncogene 26 2007 2759 2768
28. S. Sebens Müerköster, J. Kötteritzsch, C. Geismann, D. Gast, M.-L. Kruse, P. Altevogt, U.R. Fölsch, and H. Schäfer A5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma Int. J. Oncol. 34 2009 243 253
29. V. Senner, E. Kismann, S. Püttmann, N. Hoess, I. Baur, and W. Paulus L1 expressed by glioma cells promotes adhesion but not migration Glia 38 2002 146 154
30. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, and R.O. Mirimanoff Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomas N. Engl. J. Med. 352 2005 987 996
31. T. Suzuki, S. Izumoto, Y. Fujimoto, M. Maruno, Y. Ito, and T. Yoshimine Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion J. Clin. Pathol. 58 2005 166 171
32. T. Teitz, T. Wei, M.B. Valentine, E.F. Vanin, J. Grenet, V.A. Valentine, F.G. Behm, A.T. Look, J.M. Lahti, and V.J. Kidd Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nat. Med. 6 2000 529 535
33. T. Tsuzuki, S. Izumoto, T. Ohnishi, S. Hiraga, N. Arita, and T. Hayakawa Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53 J. Clin. Pathol. 51 1998 13 17
34. M. Yang, S. Adla, M.K. Temburni, V.P. Patel, E.L. Lagow, O.A. Brady, J. Tian, M.I. Boulos, and D.S. Galileo Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule Cancer Cell Int. 29 2009 9 27
35. M. Yang, Y. Li, K. Chilukuri, O.A. Brady, M.I. Boulos, J.C. Kappes, and D.S. Galileo L1 stimulation of human cell motility correlates with FAK activation J. Neurooncol. 105 2011 27 44
36. X. Yuan, J. Curtin, Y. Xiong, G. Liu, S. Waschsmann-Hogiu, D.L. Farkas, K.L. Black, and J.S. Yu Isolation of cancer stem cells from adult glioblastoma multiforme Oncogene 24 2004 9392 9400
37. T.J. Zuzak, D.F. Steinhoff, L.N. Sutto, P.C. Phillip, A. Eggert, and M.A. Grotzer Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumor/medulloblastoma Eur. J. Cancer 38 2002 83 91